Analysis of the Global Diabetes Drug Delivery Market

Future Options for End Users

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

The global diabetes drug delivery market is mainly divided into injectable drug delivery and oral drug delivery systems. The trend will continue in 2015, as four major products: Afrezza (inhalable drug delivery product of MannKind distributed by Sanofi), Tanzeum (injectable pen), Xigduo XR (oral), and Xultophy (injectable pen) enter the US and European diabetes markets. Depending on end-user acceptability of inhalable diabetes drugs, the global diabetes market can expect an increase in future investments. With the exception of one approved inhalable drug delivery system, there are no other inhalable products in the diabetes clinical pipeline at present.

Table of Contents

Executive SummaryKey FindingsKey Findings—Options in the Global Diabetes Drug Delivery MarketUnmet Needs in the Diabetes Drug Delivery MarketPumps or Pens—Future Investment Opportunities for Type 1 DiabetesScope and SegmentationKey Questions This Study Will AnswerMarket Engineering MeasurementsCEO’s PerspectiveKey Companies to Watch3 Key PredictionsMarket OverviewMarket BackgroundMarket Segmentation Market Segmentation (continued)Global Diabetes Drug Delivery Market—Type of Delivery Usage by RegionCompetitive PlaybookNew Market OpportunitiesNew Market Opportunities (continued)Pipeline of Diabetes Drug Delivery SystemsAttractiveness in Diabetes Drug Delivery MarketDrivers and Restraints—Total Diabetes DrugDelivery MarketMarket DriversMarket RestraintsForecasts and Trends—Total Diabetes DrugDelivery MarketMarket Engineering MeasurementsForecast AssumptionsRevenue ForecastRevenue Forecast by Type of Diabetes Drug DeliveryRevenue Forecast DiscussionTop CompetitorsInjectable Diabetes Drug Delivery Market AnalysisMarket Engineering MeasurementsInjectable Diabetes Drug Delivery Market—Revenue ForecastRevenue Forecast DiscussionInjectable Diabetes Drug Delivery Market—Competitive AssessmentPromising Injectable—Once-a-week Diabetes DrugOral Diabetes Drug Delivery Market AnalysisMarket Engineering MeasurementsOral Diabetes (Non-insulin) Drug Delivery Market—Revenue ForecastRevenue Forecast DiscussionOral Diabetes Drug Delivery Market—Competitive AssessmentInhalable Diabetes Drug Delivery Market AnalysisMarket Engineering MeasurementsInhalable Diabetes Drug Delivery Market—Revenue ForecastInhalable Diabetes Drug Delivery Market—Competitive AssessmentInhalable Drug Delivery System and Injectable Drug Delivery SystemNew Technologies and Trends in Diabetes Drug Delivery by RegionThe United States—New Technologies in Diabetes Drug Delivery The United States—Trends in Diabetes Drug DeliveryEurope—New Technologies in Diabetes Drug Delivery Europe—Trends in Diabetes Drug DeliveryAPAC (India)—New Technologies in Diabetes Drug Delivery APAC (India)—Trends in Diabetes Drug Delivery MarketKey Companies to WatchBecton Dickinson and CompanyGerresheimer BündeOwen Mumford LtdZosano Pharma CorporationViaCyte, Inc.Echo TherapeuticsConclusionConclusionFrost & Sullivan AwardsLegal DisclaimerAppendixMarket Engineering MethodologyDrivers ExplainedDrivers Explained (continued)Restraints ExplainedLearn More—Next Steps

Infographic





Related Research

Release Date : 19-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.